Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.

MLA

Loyer, Xavier, et al. “Liver MicroRNA-21 Is Overexpressed in Non-Alcoholic Steatohepatitis and Contributes to the Disease in Experimental Models by Inhibiting PPARα Expression.” Gut, vol. 65, no. 11, Nov. 2016, pp. 1882–94. EBSCOhost, https://doi.org/10.1136/gutjnl-2014-308883.

APA

Loyer, X., Paradis, V., Hénique, C., Vion, A.-C., Colnot, N., Guerin, C. L., Devue, C., On, S., Scetbun, J., Romain, M., Paul, J.-L., Rothenberg, M. E., Marcellin, P., Durand, F., Bedossa, P., Prip-Buus, C., Baugé, E., Staels, B., Boulanger, C. M., … Rautou, P.-E. (2016). Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut, 65(11), 1882–1894. https://doi.org/10.1136/gutjnl-2014-308883

Chicago

Loyer, Xavier, Valérie Paradis, Carole Hénique, Anne-Clémence Vion, Nathalie Colnot, Coralie L Guerin, Cécile Devue, et al. 2016. “Liver MicroRNA-21 Is Overexpressed in Non-Alcoholic Steatohepatitis and Contributes to the Disease in Experimental Models by Inhibiting PPARα Expression.” Gut 65 (11): 1882–94. doi:10.1136/gutjnl-2014-308883.